Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma
Clinical Hemorheology and Microcirculation · 27.12.2022 · 82 (4) · 361-370
DOI: 10.3233/ch-221545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hemorheology and Microcirculation, erschienen am 27.12.2022. Verfasst von Zhining Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou City, Liaoning Province, China. Hauptthemen laut MEDLINE: Lymphatic Metastasis, Microvessels, Thyroid Neoplasms, Ultrasonography. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study aims to investigate the relationship of cervical lymph node metastasis (LNM) with contrast-enhanced ultrasound (CEUS) features, microvessel density (MVD) and microvessel area (MVA) in patients with papillary thyroid carcinoma (PTC), and to evaluate the diagnostic value of CEUS for PTC. METHODS: A total of 108 patients diagnosed with PTC at the First Affiliated Hospital of Jinzhou Medical University from January 2016 to December 2018 were selected and underwent preoperative CEUS of the thyroid, surgical resection and postoperative histopathological examination of their resected lesion. They were divided into a lymphatic metastasis-positive group (LNM+, n = 61) and a lymphatic metastasis-negative group (LNM–, n = 47) based on their lymph node status. The CEUS quantitative parameters, MVD and MVA, were compared between the two groups, and risk factors for LNM were analyzed by univariate and multivariate logistic regression. RESULTS: Compared with patients with in the LNM–group, the tumor diameter and the proportion of capsule contact of patients in the LNM+group were significantly greater and the patients in this group were younger. The rise time (RT), peak intensity (PI), area under the curve (AUC), MVD, and MVA were also significantly higher in the LNM+group than in the LMN–group, while there was no significant difference in time to peak (TP), mean transit time (mTT), velocity of intensity increase (IIV), and velocity of intensity decrease (IDV) between the two groups. Univariate and multivariate correlation analysis indicated that tumor size, RT, PI, AUC, MVD, and MVA were risk factors for LNM, and ROC curves further suggested that RT had the best overall predictive performance. CONCLUSION: Tumor size, RT, PI, AUC, MVD and MVA are risk factors for LNM in PTC. In other words, CEUS is an important non-invasive and preoperative tool for evaluating PTC, with MVD and MVA identified as vital postoperative diagnostic indicators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou City, Liaoning Province, China.
- Molecular Testing Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou City, Liaoning Province, China.
Zitieren
APA
Liu, Z., & Li, C. (2022). Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma. Clinical Hemorheology and Microcirculation, 82(4), 361-370. https://doi.org/10.3233/ch-221545
Vancouver
Liu Z, Li C. Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma. Clinical Hemorheology and Microcirculation. 2022;82(4):361-370. doi:10.3233/ch-221545
BibTeX
@article{Liu2022,
author = {Liu, Zhining and Li, Chen},
title = {Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma},
journal = {Clinical Hemorheology and Microcirculation},
year = {2022},
volume = {82},
number = {4},
pages = {361--370},
doi = {10.3233/ch-221545}
}
EUVIMED